BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 32558224)

  • 1. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2.
    Chen Y; Wu N; Liu L; Dong H; Liu X
    J Cell Mol Med; 2020 Jul; 24(13):7353-7369. PubMed ID: 32558224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncCCAT1 Promotes Breast Cancer Stem Cell Function through Activating WNT/β-catenin Signaling.
    Tang T; Guo C; Xia T; Zhang R; Zen K; Pan Y; Jin L
    Theranostics; 2019; 9(24):7384-7402. PubMed ID: 31695775
    [No Abstract]   [Full Text] [Related]  

  • 4. LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.
    Han L; Yan Y; Zhao L; Liu Y; Lv X; Zhang L; Zhao Y; Zhao H; He M; Wei M
    J Cell Mol Med; 2020 Jun; 24(11):6242-6252. PubMed ID: 32307830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells.
    Kong X; Zhang J; Li J; Shao J; Fang L
    Biochem Biophys Res Commun; 2018 Jun; 501(2):486-493. PubMed ID: 29746865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-516a-3p inhibits breast cancer cell growth and EMT by blocking the Pygo2/Wnt signalling pathway.
    Chi Y; Wang F; Zhang T; Xu H; Zhang Y; Shan Z; Wu S; Fan Q; Sun Y
    J Cell Mol Med; 2019 Sep; 23(9):6295-6307. PubMed ID: 31273950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-142 regulates the tumorigenicity of human breast cancer stem cells through the canonical WNT signaling pathway.
    Isobe T; Hisamori S; Hogan DJ; Zabala M; Hendrickson DG; Dalerba P; Cai S; Scheeren F; Kuo AH; Sikandar SS; Lam JS; Qian D; Dirbas FM; Somlo G; Lao K; Brown PO; Clarke MF; Shimono Y
    Elife; 2014 Nov; 3():. PubMed ID: 25406066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
    Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
    Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00261/microRNA-550a-3p/SDPR axis affects the biological characteristics of breast cancer stem cells.
    Li Y; Wu C
    IUBMB Life; 2021 Jan; 73(1):188-201. PubMed ID: 33274565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
    Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
    BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-367-3p overexpression represses the proliferation and invasion of cervical cancer cells through downregulation of SPAG5-mediated Wnt/β-catenin signalling.
    Yang T; Tian S; Wang L; Wang Y; Zhao J
    Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):687-695. PubMed ID: 31792998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging roles of circRNA_NEK6 targeting miR-370-3p in the proliferation and invasion of thyroid cancer via Wnt signaling pathway.
    Chen F; Feng Z; Zhu J; Liu P; Yang C; Huang R; Deng Z
    Cancer Biol Ther; 2018; 19(12):1139-1152. PubMed ID: 30207869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivery of LNA-antimiR-142-3p by Mesenchymal Stem Cells-Derived Exosomes to Breast Cancer Stem Cells Reduces Tumorigenicity.
    Naseri Z; Oskuee RK; Forouzandeh-Moghadam M; Jaafari MR
    Stem Cell Rev Rep; 2020 Jun; 16(3):541-556. PubMed ID: 31898802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
    Liu F; Liu Y; Shen J; Zhang G; Han J
    Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4.
    Chang S; Sun G; Zhang D; Li Q; Qian H
    Cell Death Dis; 2020 Jul; 11(7):592. PubMed ID: 32719361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-638 represses the stem cell characteristics of breast cancer cells by targeting E2F2.
    Lin QY; Wang JQ; Wu LL; Zheng WE; Chen PR
    Breast Cancer; 2020 Jan; 27(1):147-158. PubMed ID: 31410735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Over-expression of miR-151a-3p inhibits proliferation and migration of PC-3 prostate cancer cells].
    Zhang Y; Hao T; Zhang H; Wei P; Li X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Mar; 34(3):247-252. PubMed ID: 29773107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin mediates induction of miR-708 to inhibit self-renewal and chemoresistance of breast cancer stem cells through targeting CD47.
    Tan W; Tang H; Jiang X; Ye F; Huang L; Shi D; Li L; Huang X; Li L; Xie X; Xie X
    J Cell Mol Med; 2019 Sep; 23(9):5994-6004. PubMed ID: 31273952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.